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Abstract
Background: Most public health guidelines recommend that adults participate in 30 minutes of
moderate intensity physical activity on most days of the week. Establishing new ways to achieve
these targets in sedentary populations need to be explored. This research evaluated whether the
daily use of pedometers could increase physical activity and improve health outcomes in sedentary
overweight and obese women.
Methods: Twenty six overweight and obese middle-aged women were randomized into two
groups: The control group was not able to record their steps daily, whilst the pedometer group,
were asked to record the number of steps on a daily basis for 12 weeks.
Results: Our data showed that the pedometer group significantly increased their steps/day, by
36%, at the end of the 12 weeks, whereas the control group's physical activity levels remained
unchanged. There was no significant difference in weight or body fat composition in the pedometer
group compared to the control group. However, there was a significant decrease in systolic blood
pressure in the pedometer group (112.8 ± 2.44 mm Hg) compared to the control group (117.3 ±
2.03 mm Hg) (p = 0.003).
Conclusion: In conclusion, this pilot study shows that the combination of having step goals and
immediate feedback from using a pedometer was effective in increasing physical activity levels in
sedentary overweight and obese women.
Trial registration: ACTRN12609000176268
Background
Obesity has reached epidemic proportions globally, with
more than 1 billion adults overweight and at least 300
million of these clinically obese [1]. Obesity carries with
it significantly higher risks for developing diabetes, hyper-
tension, stroke, coronary artery disease, sleep apnoea,
joint and respiratory problems [2-4].
Studies have shown that exercise can elicit improvements
in cardiovascular fitness, body composition, blood lipid
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profile and retention of essential muscle mass [5]. Regular
physical activity also improves, mental health states [6],
blood pressure [7], type 2 diabetes [8], protects against
some cancers [9] and the risk of osteoporosis [10]. Despite
increased knowledge about the benefits of exercise, weight
loss and a healthy diet for psychological and physiological
well-being, motivating sedentary overweight obese adults
is a difficult task. Even those who initiate changes often
find it difficult to comply with a program for any length
of time, most falling back into their old inactive habits
after an intervention ends [11]. Most public health guide-
lines recommend that adults participate in 30 minutes of
moderate intensity physical activity on most, if not all
days of the week [12-15]. However, the 2008 US Physical
Activity Guidelines Advisory Committee recommends
that overweight/obese adults should accumulate at least
60 minutes of activity on most days of the week [16].
Ensuring that a sufficient amount of physical activity has
been accumulated daily to attain health benefits can be
very difficult, especially in the overweight and obese.
Therefore, establishing new ways to achieve these higher
targets need to be explored.
It is generally recommended that lifestyle-based (or
home-based) increases in physical activity, as opposed to
structured exercise programs (gym, walking trainers,
supervised programs) are more likely to be successful in
facilitating increased physical activity and weight loss over
the long-term [17,18]. Studies have shown that the daily
use of pedometers is associated with significant increases
in physical activity [19]. Feedback from pedometer step
counts has been shown to prompt behaviour change as
they raise awareness of current walking behaviours [20],
can be used to motivate [21], and to self-monitor [20,21].
A meta-analysis of 26 RCTs and observational studies of
pedometer use in adults reported a significant increase in
the number of steps walked per day [19]. However, the
authors concluded that some limitations of the included
studies were: 1) the studies were all of relatively short
duration and the extent to which these results are durable
over the long term is unknown; 2) few studies provided
detailed information about their participants or evaluated
more than one of the outcomes of interest 3) many inter-
ventions included the use of two or more components
(eg, pedometers, step goals, diaries, counselling). Hence
studies investigating pedometer use without a step goal
and/or without physical activity counselling are required,
including comparisons between participants who can see
their daily step counts vs pedometer use in which they are
blinded to their daily step counts.
The aim of this pilot study was to investigate whether the
daily recording of steps using pedometers could increase
physical activity in sedentary overweight and obese
women. We hypothesised that the daily use of pedometers
would act as prompt to increase daily physical activity in
sedentary overweight and obese women. In this study
middle-aged women were targeted as > 50% of this group
are overweight and therefore at high risk for developing
cardiovascular disease, diabetes and hypertension [2].
Women are specifically targeted in this pilot study as they
generally have a large input into their families. Thus, any
lifestyle changes have the potential to flow on and affect
their family members (spouses, children).
Methods
Participants
Thirty middle aged (35 – 55 yrs old), sedentary, over-
weight and obese women (body mass index {BMI} > 25
and < 35 kg/m2) were recruited from the local community
newspapers in Perth, Australia.
Interested participants were initially screened by the
research assistant using a telephone questionnaire. Those
who were suitable then attended a group orientation
meeting where details of the study were explained before
written consent was obtained. Exclusion criteria included
current chronic medical and psychological disease, major
systemic illness, renal failure, pregnancy, lactating or
planning to become pregnant, smoking, hypothyroidism,
diabetes mellitus, pre-existing heart conditions or gas-
trointestinal surgery and greater than two hours of moder-
ate intensity physical activity per week. Written informed
consent from each participant was obtained prior to par-
ticipating in the study. The Ethics Committee of Curtin
University reviewed and approved all procedures
Experimental Protocol
In this 12 week study, overweight and obese sedentary
middle aged women were randomised into two groups: a
'pedometer' group and a 'control' group. Participants in
the pedometer group were told to record their pedometer
steps on a daily basis for 12 weeks; those in the control
group were asked to wear a sealed pedometer for 12 weeks
with weekly recording.
To collect baseline data, all thirty participants were asked
to wear a sealed Yamax Digi-Walker SW-200 pedometer to
record the amount of steps they accumulated over a one
week period. This pedometer has an overall mean abso-
lute error of 3% [22]. Two studies have compared 13 ped-
ometer models and found that Yamax Digiwalker SW-200
pedometer to be the one of the most accurate and suitable
for research [23,24]. The accuracy of the pedometer on
each participant was checked by the means of a 20 step
test at the outset, the acceptance criteria being +/-2 steps.
Participants wore the pedometer clipped to their clothing
at the waist, centred over the foot. Thirty participants were
then randomised to two groups by the research assistant
using a blocked randomisation method. The controlBMC Public Health 2009, 9:309 http://www.biomedcentral.com/1471-2458/9/309
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group wore a sealed pedometer for 12 weeks and therefore
had no knowledge of their record of steps/day. The ped-
ometer was sealed with tape so that the number of steps/
day was concealed. This seal was only broken once per
week by the participant so that the total weekly steps
could be recorded by them on a calendar provided. They
were then asked to reset the pedometer to zero each week
and seal the pedometer with tape. Participants signed a
form to acknowledge that they understood these instruc-
tions and would abide by them. The pedometer group
wore an unsealed pedometer. Hence they were able to
open and observe their number of steps performed
throughout the day. Participants in the pedometer group
were instructed to record accumulated steps/day on a cal-
endar and to reset the pedometer to zero each day.
At baseline, both groups were then given the National
Australian Physical Activity Guidelines [12]. At baseline,
information from these guidelines such as intensity, dura-
tion, prompts for exercise (ie, stairs or elevators) and
relapse prevention etc were reviewed with the partici-
pants. The pedometer group was also encouraged to reach
a daily step goal of 10,000 steps/day. No step goals were
set for the control group. At baseline, participants from
both groups were encouraged to initially set small achiev-
able goals like 10 minute walks and then to gradually
increase the goal each week to at least 30 min/day. No fur-
ther advice was given to either the pedometer or control
group regarding physical activity after this initial consulta-
tion. Physical activity was assessed at baseline and at 12
weeks using short-form International Physical Activity
Questionnaire (IPAQ), which provides information on
the time spent walking, in moderate physical activity, in
vigorous physical activity and total physical activity in
(MET·min/wk) (MET = Metabolic Equivalent Task) in a
usual week. This version of the IPAQ has been found to be
valid and reliable [25].
Participants were asked to maintain their usual dietary
intake throughout the duration of the study. The mainte-
nance of dietary intake over the course of the trial was
monitored through the completion of 3-day food diaries,
which included two week days and one weekend day, at
the start and finish of the study. Energy and macronutri-
ent intakes from the participants' combined food records
were calculated using Food Works (Version 3 Xyris Soft-
ware, 2002) based on data from the AUSNUT database.
Physical examination
Participants were assessed at baseline and 12 weeks. They
underwent a brief physical examination, including resting
heart rate (HR) and blood pressure, weight, waist and hip
measurements. Height measurements were taken using a
mechanical stadiometer (Surgical and Medical Products,
Hills, Australia. BMI (kg/m2) was calculated from weight
and height measurements. Waist (at umbilicus) and hip
circumference were measured from which Waist to Hip
ratio (WHR) was calculated. Weight measurements were
taken using Tanita scales (UM-018 Digital Scales, Tanita
Corporation, Tokyo, Japan), with patients dressed in light
clothing without shoes. Body composition was also meas-
ured using the RJL Systems BIA – 101 Body Composition
Analyzer (USA). These standardized protocols have been
established in our laboratory.
Statistical analysis
Statistical analysis was conducted using SPSS 17 for Win-
dows (SPSS Inc., Chicago, IL). Data are expressed as mean
(SEM) and assessed for normality. Comparison of base-
line characteristics between each group was undertaken by
one way analysis of variance. Differences within groups
were determined using a two-sided paired t-test. Using
one-way analysis of covariance with the baseline data as
the covariate, differences between groups at week 6 and
12 were conducted. Statistical differences were analysed
further by post-hoc analysis using the Least Square Differ-
ences (LSD) method. Statistical significance was consid-
ered at p < 0.05. Sample size calculation was based on a
predicted change of 20% in steps/day between control
and groups as suggested in previous studies [19,26,27].
Assuming a standard deviation of 20%, a sample size of
12 participants per group provides sufficient power (80%)
to detect changes at the 5% significance level. A total of 30
participants were recruited to ensure adequate numbers in
the event of participants choosing to withdraw from the
study.
Results
A total of 30 participants (15 participants/group) were ini-
tially recruited and started the study. However a total of
twenty six completed the study. Four participants with-
drew from the study (2 participants per group) due to per-
sonal issues. Two participants withdrew in week 2 from
the pedometer group and the other two from the control
group withdrew at week 3 and 4. Results were reported on
the remaining 26 participants, with 13 participants in the
pedometer group and 13 participants in the control
group. Baseline characteristics of participants, such as
steps/day, height, weight, age did not significantly differ
between the groups (Table 1).
Figure 1 shows no significant difference in the number of
steps at baseline between the two groups. However, there
was a significant increase in the number of steps with the
pedometer group versus the control group at 6 and 12
weeks intervention (p = 0.04 and p = 0.03, respectively).
At 12 weeks, the pedometer group had a 32% higher
number of steps/day than the control group. The control
group remained unchanged in the number of steps during
the 12-week intervention. For the pedometer group, theBMC Public Health 2009, 9:309 http://www.biomedcentral.com/1471-2458/9/309
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daily average number of steps at weeks six (8321 ± 884
steps per day) and twelve (9703 ± 921 steps per day) were
significantly higher than the baseline daily average of
6242 ± 541 steps per day (p = 0.046 and p = 0.035, respec-
tively). At week twelve, the pedometer group was taking
an average of 3461 steps per day more (36% increase)
than at baseline.
Table 2 shows the anthropometric and blood pressure
measurements at baseline and 12 weeks of the 2 groups.
There was no significant differences within groups or
between groups in waist, BMI, waist/hip ratio, HR or %
body fat at 12 weeks. Systolic blood pressure decreased
significantly by 4.7% at week 12 compared with baseline
in the pedometer group (p = 0.018). The pedometer group
was found to have a significantly lower systolic blood
pressure (112.8 ± 2.44 mm Hg) at 12 weeks compared to
the control group (117.3 ± 2.03 mm Hg) (p = 0.003).
There were no significant changes to diastolic blood pres-
sure (baseline versus 12 weeks) or between groups at 12
weeks.
Table 1: Mean demographic data at baseline for the control and 
pedometer groups
Group Pedometer (n = 13) Control
(n = 13)
P value
Age (years) 42 ± 9.2 44 ± 6.9 0.287
Weight (kg) 77.84 ± 1.91 77.16 ± 2.45 0.543
Height (cm) 161.33 ± 1.36 164.19 ± 1.88 0.676
BMI (kg/m2) 29.92 ± 0.68 28.60 ± 0.75 0.423
Mean steps/day 6242 ± 541 6574 ± 606 0.430
Values are represented as mean ± s.e.m
*Denotes significance at p < 0.05
P-values represent the comparison of control group vs pedometer 
group at baseline
Average number of daily steps taken at baseline, week 6 and week 12 by the control and pedometer groups Figure 1
Average number of daily steps taken at baseline, week 6 and week 12 by the control and pedometer groups. 
The average steps/day were measured at baseline, week 6 and week 12 in both groups. Data is expressed as means ± SEM. Dif-
ferent letters above bar graphs indicate significance at p < 0.05. * Significant difference (P < 0.05) within group (baseline versus 
6 weeks). * Significant difference (P < 0.05) within group (baseline versus 12 weeks).BMC Public Health 2009, 9:309 http://www.biomedcentral.com/1471-2458/9/309
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Table 2: Anthropometric, resting heart rate and blood pressure at baseline and week 12 for the control and pedometer groups.
Variable Pedometer Control P-value
Baseline Week 12 Baseline Week 12 Week 12
Weight
(kg)
77.84 ± 1.91 77.92 ± 2.28 77.16 ± 2.45 76.94 ± 2.55 0.799
Height
(cm)
161.33 ± 1.36 161.35 ± 1.46 164.19 ± 1.88 163.78 ± 1.85 0.366
BMI (kg/m2) 29.92 ± 0.68 30.08 ± 0.80 28.60 ± 0.75 28.66 ± 0.81 0.962
Waist (cm) 97 ± 2.24 97.35 ± 3.16 95.5 ± 2.98 95.4 ± 2.72 0.820
Hip (cm) 110.62 ± 2.32 112.44 ± 2.68 109.24 ± 1.92 110.69 ± 1.75 0.768
WHR 0.88 ± 0.01 0.86 ± 0.01 0.87 ± 0.02 0.86 ± 0.02 0.637
% Body Fat 41.73 ± 0.79 41.6 ± 0.97 41.01 ± 1.11 40.46 ± 1.13 0.573
Resting Heart Rate 60.1 ± 2.34 62.3 ± 2.27 61.8 ± 1.93 62.5 ± 2.56 0.430
BP Systolic
(mm Hg)
118.3 ± 2.55 112.8 ± 2.44* a 116.9 ± 2.82 117.3 ± 2.03b 0.003
BP Diastolic
(mm Hg)
79.13 ± 2.12 75.59 ± 2.41 76.05 ± 2.39 76.97 ± 2.28 0.179
Values are represented as mean ± s.e.m
P-values represent the between group comparison of the control vs pedometer group at week 12.
There were no significant differences at baseline between groups.
*Significant difference (P < 0.05) within group (Baseline versus 12 weeks)
Significant difference (P < 0.05) between control group and pedometer group at 12 weeks is indicated by different letters.
Percentage body fat was measured using the RJL Systems BIA – 101 Body Composition Analyzer
Table 3: The macronutrient composition of diets from participants 3 day food records at baseline and 12 weeks for the control and 
pedometer groups
Variable Pedometer (n = 13) Control (n = 13) P-value
Baseline Week 12 Baseline Week 12 Week 12
Energy (kJ) 9024 ± 1080 8854 ± 687 9497 ± 1571 9146 ± 988 0.481
Protein (g) 99.9 ± 12.5 95 ± 9.87 105.8 ± 23 97.3 ± 9.8 0.820
Fat (g) 90.5 ± 11.33 87 ± 9.7 92.9 ± 18.7 89 ± 8.8 0.571
Carbohydrate (g) 219.7 ± 30.1 213 ± 22.3 229.7 ± 32.5 219 ± 22.4 0.128
Fibre (g) 21.7 ± 1.9 23.9 ± 2.3 24 ± 2.1 24.9 ± 3.6 0.136
Values are represented as mean ± s.e.m
P-values represent the between group comparison of the control vs pedometer group at week 12.
There were no significant differences at baseline between groups.
There were no significant differences between groups at 12 weeks.
There were no significant within group differences.BMC Public Health 2009, 9:309 http://www.biomedcentral.com/1471-2458/9/309
Page 6 of 9
(page number not for citation purposes)
Table 3 shows that there were no significant differences
between the groups in the macronutrient content of their
diets at baseline or at 12 weeks. Table 4 shows that time
doing moderate or vigorous physical activity was not sig-
nificantly different between the control and pedometer
groups. However, there was a significant increase in time
spent walking in the pedometer group compared to the
control group at 12 weeks and from baseline. Although
time spent doing moderate activity and total physical
activity increased in the pedometer group versus the con-
trol group at 12 weeks this was not significant.
Discussion
In this study we tested whether the daily use of pedome-
ters could promote increased physical activity in sedentary
overweight and obese women. Our results showed that
those in the pedometer group who were able to record
their daily steps had a significant increase in their number
of steps/day after 6 and 12 weeks compared to those in the
control group who could not monitor their steps on a
daily basis. Setting a step goal and the immediate feed-
back from the pedometer may be a key motivational fac-
tor for increasing physical activity in the pedometer
group. The increase in the daily number of steps/day was
mainly through walking activity as suggested by the IPAQ
results (Table 4). There were no significant differences in
anthropometric measurements between the pedometer
and control groups.
Our results are consistent with previous research indicat-
ing that the daily use of pedometers is effective in increas-
ing walking behaviour. A meta-analysis of 26 RCTs and
observational studies of pedometer use in adults reported
a significant increase in the number of steps walked per
day [19]. Participants in the RCTs who used pedometers,
recorded their steps and had a step goal increased their
physical activity by an average of 2491 steps per day more
than pedometer users who did not have a step goal. In the
meta-analysis study, pedometer users increased their
number of steps by 27% over baseline [19]. Bravata et al.,
[19], found that step-count goal was an important predi-
cator of increasing physical activity. Similarly in our study,
those in the control group who were not given a daily step
goal and unable to open their pedometers on a daily basis,
had no significant increase in their physical activity over
baseline. On the other hand, the pedometer group had a
step goal, were able to open view their pedometer on a
daily basis and record steps. Since pedometers provide a
quantifiable walking measure, they enable participants to
track and record progress from a baseline reference point.
Studies have shown that immediate feedback from the
pedometers enable participants to set realistic goals, act as
an environmental cue, raise awareness of current walking
behaviours [20], to motivate [21], to self-monitor [20,21],
and to increase walking behaviours [7,28].
We did not observe any changes in anthropometric meas-
ures in this study, which is consistent with other studies
[29]. It has been suggested that 60 to 90 min of moderate
intensity exercise on most days of the week would be
required for weight loss [30]. Therefore, the extra 3461
steps steps/day (equivalent to 30 min of physical activity)
performed by the pedometer group may not have been
adequate to see changes in anthropometric measures in
this group [31]. Anthropometric measures may have
remained stable, despite increased physical activity, due to
Table 4: Physical activity data from the International Physical Activity Questionnaire (IPAQ) at baseline and 12 weeks for the control 
and pedometer groups
Variable Pedometer Control P-value
Baseline Week 12 Baseline Week 12 Week 12
Walking
(MET·min/wk)
244.5 ± 122.2 589.3 ± 167.2* a 224.6 ± 102 201.4 ± 114.6b 0.036
Moderate activity
(MET·min/wk)
161.5 ± 44.5 214.3 ± 67.5 177.2 ± 45.5 174.6 ± 54.5 0.234
Vigorous activity
(MET·min/wk)
57.8 ± 34 59.5 ± 26 62.8 ± 23.3 61.3 ± 138.3 0.146
Total activity
(MET·min/wk)
365.8 ± 195.4 689 ± 295.5 455.8 ± 203.5 389 ± 175.5 0.274
Values are represented as mean ± s.e.m
P-values represent the between group comparison of the control vs pedometer group at week 12.
There were no significant differences at baseline between groups.
*Significant difference (P < 0.05) within group (Baseline versus 12 weeks)
Significant difference (P < 0.05) between control group and pedometer group at 12 weeks is indicated by different letters.BMC Public Health 2009, 9:309 http://www.biomedcentral.com/1471-2458/9/309
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nutritional compensation. However, we did not observe
any increase in dietary intake at 12 weeks (Table 3). Lack
of change in nutritional intake may be due to under
reporting by overweight and obese groups as shown in
previous studies [32,33].
Current public health guidelines suggest that ≈ 30 min of
moderate-intensity activity/day on most days of the week
provides health benefits and reduces risk for a range of
conditions in all population groups [12-14]. However,
new recommendations by the US Physical Activity Guide-
lines Advisory Committee suggests that overweight/obese
adults should accumulate at least 60 minutes of activity
on most days of the week for weight loss [16]. Brisk walk-
ing for 60 minutes is equivalent to approximately 6,000
steps [34]. This means that overweight individuals would
need to accumulate an extra 6000 steps for weight loss.
Therefore, new ways are required to help achieve this
higher target. In our study, sedentary overweight and
obese women were asked to comply with the National
Australian guidelines for adults and increase their physical
activity by 30 min/day. Those in the pedometer group
with 6242 ± 541 steps/day at baseline, reached an average
of 9703 ± 921 steps/day after 12 weeks, an increase of
more than 3000 steps/day. However, overweight adults in
our study would need to accumulate at least 12,000 steps
per day to comply with these new guidelines and achieve
weight loss. As suggested by the the US Physical Activity
Guidelines Advisory Committee, energy intake (diet)
must be also be considered for weight control by this par-
ticular group [16].
The increase in daily steps in the pedometer group was
mainly through walking more (Table 4). It has been pre-
viously demonstrated that walking is the single easiest
way for people to increase their physical activity and sus-
tain it over the long term [35]. Walking, which is "self
paced" is the most frequently reported physical activity
and most preferred in the overweight and obese as it is
low-impact with little risk of injury [12,36,37].
This study showed improvements in systolic blood pres-
sure in the pedometer group after 12 weeks compared to
the control group. As dietary intake in the pedometer
group at 12 weeks did not significantly change from base-
line we can comment that improvements in blood pres-
sure are most likely due to an increase in physical activity
in this group and unlikely to be influenced by any changes
in dietary intake. In a meta-analysis of 26 RCTs and obser-
vational studies, intervention participants, who had
increased their physical activity levels, had a statistically
significant decrease in systolic blood pressure of 3.8 mm
Hg and diastolic blood pressure of 0.3 mm Hg [19]. This
reduction in systolic blood pressure was independent of
decreases in BMI. Our results are also consistent with a
meta-analysis of 54 studies conducted by Whelton et al.
[38] showing that aerobic exercise reduced blood pressure
in both hypertensive and normotensive adults. All fre-
quencies, intensities, and types of aerobic exercise low-
ered blood pressure. By highlighting the health benefits of
physical activity, health professionals can use such evi-
dence to encourage overweight and obese patients, who
are frustrated by an inability to lose weight, to engage in
physical activity.
In this study we asked our overweight and obese partici-
pants to comply with the Australian Physical activity
guidelines which advises most adults participate in 30
minutes of moderate intensity physical activity on most
days. Further work is required to demonstrate whether
using pedometers on a daily basis could help the over-
weight and obese accumulate at least 60 minutes of activ-
ity on most days of the week, thereby meeting the new
recommendations for physical activity advised for this
group [16]. It is possible that changes in anthropometric
measures could be observed after 12 weeks in this group
with 60 min targets. One of the limitations of this study
was using a pedometer without a memory chip, where
only a total step count for the week was available for the
control group. There is evidence to suggest that despite
participants not being able to see their daily step count
when wearing sealed pedometers, a certain amount of
reactivity (i.e. steps are higher) occurs during the first 2–3
days of monitoring under these conditions [39]. For
future studies using pedometers with a memory chip
which is capable of storing daily step counts over a period
of seven days could be used. A study in overweight and
obese adults has shown that a piezo-electric pedometer is
more accurate than a Yamax Digi-Walker in those with
higher BMI [40]. This type of pedometer could be used in
future studies for studying walking behaviours in over-
weight and obese individuals. Another limitation of this
study was the lack of detail in how the participants chose
to perform their physical activity. It is also suggested that
in addition to daily activity, exercise should be performed
in bouts of 10 mins and resistance exercise should be per-
formed two times per week [15,29]. Although those in the
pedometer group reported that they had increased their
walking, the duration of each walking bout is unclear.
Recommendations regarding resistance training were not
highlighted to the participants.
Conclusion
In conclusion, this pilot study shows that the combina-
tion of having step goals and immediate feedback from
using a pedometer was effective in increasing physical
activity levels in sedentary overweight and obese women.
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